Natucure Hemorrhoid Cream
NDC Package 85248-044-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Natucure Hemorrhoid (lidocaine 4% phenylephrine hcl 0.25% hemorrhoid) cream is children under 12 years of age consult your pediatrician. This formulation utilizes a cream delivery system. Marketed by Jiangxi Yudexi Pharmaceutical Co., Ltd, this product is identified by NDC 85248-044 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
85248-044-01
Package Description
42.5 g in 1 BOTTLE
Product Code
85248-044
11-Digit Billing Format
85248004401
RxNorm Crosswalk
  • RxCUI: 2529640 - lidocaine 4 % / phenylephrine hydrochloride 0.25 % Rectal Cream
  • RxCUI: 2529640 - lidocaine 40 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Cream

Clinical Specifications

Proprietary Name
Natucure Hemorrhoid
Non-Proprietary Name
Lidocaine 4% Phenylephrine Hcl 0.25% Hemorrhoid
Substance Name
Lidocaine; Phenylephrine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Children under 12 years of age consult your pediatrician. Adults: apply to affected area up to 3 times daily.Clean affected area with mild soap and warm water, rinse thoroughly, and then gently dry (patting or blotting) with tissue or soft cloth before use. To use dispensing cap, attach it to tube, lubricate well then gently insert part way into anus and squeeze tube to deliver medication. Thoroughly cleanse dispensing cap after use with mild soap and warm water and rinse thoroughly.

Regulatory & Marketing

Labeler Name
Jiangxi Yudexi Pharmaceutical Co., Ltd
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-03-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85248-044-01 identifies a specific commercial package of 42.5 g in 1 bottle of Natucure Hemorrhoid, a human over the counter drug labeled by Jiangxi Yudexi Pharmaceutical Co., Ltd. This cream is formulated for topical use and contains lidocaine; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jiangxi Yudexi Pharmaceutical Co., Ltd on February 03, 2026. The current certification is valid through December 31, 2027.

How is this Jiangxi Yudexi Pharmaceutical Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85248004401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85248-044-01
11-Digit CMS (5-4-2)
85248-0044-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.